Breast cancer: Should gastrointestinal bacteria be on our radar screen?

Cancer Research

Volumn 67, Issue 3, 2007, Pages 847-850

  Rao, Varada P ^a   Poutahidis, Theofilos ^a,b   Fox, James G ^a   Erdman, Susan E ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; APC PROTEIN; INTERLEUKIN 10; RAG2 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

BREAST CANCER; CAMPYLOBACTER JEJUNI; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; GENETIC SUSCEPTIBILITY; HELICOBACTER HEPATICUS; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; INTESTINE FLORA; LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANIMALS; BREAST NEOPLASMS; FEMALE; GASTROINTESTINAL TRACT; HUMANS;

EID: 33847041537     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-3468     Document Type: Review

References (29)

1. Bange J, Zwick E, Ullrich A. Molecular targets for breast cancer therapy and prevention. Nat Med 2001;7: 548-52.
2. ACS cancer facts and figures 2004. US cancer fact and figures 2004.
3. Madigan MP, Ziegler RG, Benichou J, Byrne C, Hoover RN. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 1995;87:1681-5.
4. Ness RB, Cauley JA. Antibiotics and breast cancer - what's the meaning of this? JAMA 2004;291:880-1.
5. Wang D, Dubois RN. Cyclooxygenase-2: a potential target in breast cancer. Semin Oncol 2004;31:64-73.
6. Moss SF, Blaser MJ. Mechanisms of disease: inflammation and the origins of cancer. Nat Clin Pract Oncol 2005;2:90-7; quiz 1 p following 113.
7. Fox JG, Wang TC. Inflammation, atrophy and gastric cancer. J Clin Invest 2007;117:60-9.
8. + regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol 2003;162:691-702.
9. + T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003;197:111-9.
10. Powrie F, Maloy KJ. Immunology. Regulating the regulators. Science 2003;299:1030-1.
11. Cardiff RD, Anver MR, Gusterson BA, et al. The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 2000;19:968-88.
12. Rao VP, Poutahidis T, Ge Z, et al. Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res 2006;66:7395-400.
13. Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990;247:322-4.
14. Corpet DE, Pierre F. Point: from animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system. Cancer Epidemiol Biomarkers Prev 2003;12:391-400.
15. Moser AR, Mattes EM, Dove WF, Lindstrom MJ, Haag JD, Gould MN. ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. Proc Natl Acad Sci U S A 1993;90:8977-81.
16. + CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/+) mice. Cancer Res 2006;66:57-61.
17. Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006;124:823-35.
18. Balkwill F, Coussens LM. Cancer: an inflammatory link. Nature 2004;431:405-6.
19. + regulatory T cells. Immunol Lett 2005;97:189-92.
20. Sakaguchi S, Ono M, Setoguchi R, et al. Foxp3CD25CD4 natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006;212:8-27.
21. + regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice. Cancer Res 2005;65:3998-4004.
22. Erdman SE, Rao VP, Poutahidis T, et al. CD4(+) CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice. Cancer Res 2003;63:6042-50.
23. Houghton J, Stoicov C, Nomura S, et al. Gastric cancer originating from bone marrow-derived cells. Science 2004;306:1568-71.
24. Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 2001;1:69-75.
25. Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol 2005;6:353-60.
26. Di Giacinto C, Marinaro M, Sanchez M, Strober W, Boirivant M. Probiotics ameliorate recurrent Thl-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-β-bearing regulatory cells. J Immunol 2005;174:3237-46.
27. Coletta PL, Muller AM, Jones EA, et al. Lymphodepletion in the ApcMin/+ mouse model of intestinal tumorigenesis. Blood 2004;103:1050-8.
28. Gounari F, Chang R, Cowan J, et al. Loss of adenomatous polyposis coli gene function disrupts thymic development Nat Immunol 2005;6:800-9.
29. Pure E, Allison JP, Schreiber BD. Breaking down the barriers to cancer immunotherapy. Nat Immunol 2005;6:1207-10.